Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Short term Debt: 2017-2024

Historic Short term Debt for Organogenesis Holdings (ORGO) over the last 6 years, with Sep 2024 value amounting to $6.0 million.

  • Organogenesis Holdings' Short term Debt rose 8.77% to $6.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $6.0 million, marking a year-over-year increase of 8.77%. This contributed to the annual value of $5.5 million for FY2023, which is 20.89% up from last year.
  • Per Organogenesis Holdings' latest filing, its Short term Debt stood at $6.0 million for Q3 2024, which was up 3.58% from $5.8 million recorded in Q2 2024.
  • Organogenesis Holdings' Short term Debt's 5-year high stood at $22.5 million during Q2 2021, with a 5-year trough of $1.7 million in Q1 2020.
  • Moreover, its 3-year median value for Short term Debt was $5.5 million (2023), whereas its average is $5.0 million.
  • The largest annual percentage gain for Organogenesis Holdings' Short term Debt in the last 5 years was 912.30% (2021), contrasted with its biggest fall of 84.06% (2021).
  • Organogenesis Holdings' Short term Debt (Quarterly) stood at $16.7 million in 2020, then plummeted by 84.06% to $2.7 million in 2021, then soared by 70.86% to $4.5 million in 2022, then grew by 20.89% to $5.5 million in 2023, then increased by 8.77% to $6.0 million in 2024.
  • Its last three reported values are $6.0 million in Q3 2024, $5.8 million for Q2 2024, and $5.5 million during Q1 2024.